New Dual Pan-PI3K/mTOR Inhibitor: Design, Synthesis, Cytotoxic Action, Permeation, Metabolic Stability, and In Silico Protein–Ligand Interaction
ACS Omega · 17.02.2026 · 11 (6) · 9719-9733
DOI: 10.1021/acsomega.5c10162 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 05.02.2026. Verfasst von Cristiane Aparecida E Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Avaliação E Síntese de Substâncias Bioativas (LASSBio), Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Aven…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Instituto Nacional de Ci?ncia e Tecnologia da Criosfera, Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
The PI3K/AKT/mTOR pathway is frequently dysregulated in cancer, contributing to tumor progression, drug resistance, and poor prognosis. Dual PI3K/mTOR inhibitors such as gedatolisib have shown clinical promise, but they still face challenges, including low solubility, poor metabolic stability, and limited activity against resistant tumor phenotypes. Here, we report a proof-of-concept study exploring structural modifications on compound 5f, a simplified gedatolisib analog, to generate a novel small subseries of morpholino-triazine derivatives (9a-f). The goal was to improve molecular interactions within the affinity site of PI3K, investigate the impact on isoform selectivity, and evaluate pharmacological properties relevant to early optimization. Among these, compound 9a (LASSBio-2337) emerged as a dual pan-PI3K/mTOR inhibitor (IC50: 0.3-5.8 μM), showing cytotoxic effects in leukemia cell lines (CC50: 4.37-9.44 μM), including those with multidrug resistance (Lucena, MDR phenotype), while sparing nontumor hPBMCs. Although aqueous insoluble, 9a displayed moderate PAMPA-GIT permeability and low metabolic stability in rat liver microsomes, underscoring its potential as a lead for further optimization. This integrated study provides structural, mechanistic, and pharmacokinetic insights to guide next-generation PI3K/mTOR inhibitor design.
Autor:innen und Institutionen
- Laboratório de Avaliação E Síntese de Substâncias Bioativas (LASSBio), Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Cidade Universitária, Rio de Janeiro, Ri…
- Programa de Pós-Graduação Em Farmacologia E Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Cidade Universitária, Rio de Janeiro, Rio de Jan…
- Laboratório de Glicobiologia (LABGLICO), Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Cidade Universitária, Rio de Janeiro, Rio de Janeiro CEP 219…
ORCID-Profile: Wesley Leandro Gouveia, Lidia Moreira Lima
Förderung
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Instituto Nacional de Ci?ncia e Tecnologia da Criosfera
- Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
Zitieren
APA
Aparecida E Silva, C., Pillpe-Meza, R. M., Gouveia, W. L., da Silva Trindade, J. D., Barbosa, G., Vieira, A. M. S., Tolomeu, H. V., Pereira, R. F., Santos, C. A. D. N., Freire-de-Lima, L., & Lima, L. M. (2026). New Dual Pan-PI3K/mTOR Inhibitor: Design, Synthesis, Cytotoxic Action, Permeation, Metabolic Stability, and In Silico Protein–Ligand Interaction. ACS Omega, 11(6), 9719-9733. https://doi.org/10.1021/acsomega.5c10162
Vancouver
Aparecida E Silva C, Pillpe-Meza RM, Gouveia WL, da Silva Trindade JD, Barbosa G, Vieira AMS, et al. New Dual Pan-PI3K/mTOR Inhibitor: Design, Synthesis, Cytotoxic Action, Permeation, Metabolic Stability, and In Silico Protein–Ligand Interaction. ACS Omega. 2026;11(6):9719-9733. doi:10.1021/acsomega.5c10162
BibTeX
@article{AparecidaESilva2026,
author = {Aparecida E Silva, Cristiane and Pillpe-Meza, Raysa Magali and Gouveia, Wesley Leandro and da Silva Trindade, Joana D'Arc and Barbosa, Gisele and Vieira, Amanda Marques Seixas and Tolomeu, Heber Victor and Pereira, Rayane França and Santos, Carlos Antônio do Nascimento and Freire-de-Lima, Leonardo and Lima, Lidia Moreira},
title = {New Dual Pan-PI3K/mTOR Inhibitor: Design, Synthesis, Cytotoxic Action, Permeation, Metabolic Stability, and In Silico Protein–Ligand Interaction},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {6},
pages = {9719--9733},
doi = {10.1021/acsomega.5c10162}
}
EUVIMED